Method for preparing co-differentiated cell therapy

Abstract

The present invention relates to a method for manufacturing a codifferentiated cell therapy agent. More specifically, the cell therapy agent of the present invention is manufactured through the codifferentiation of immature myotubes that have been differentiated in vitro, thereby allowing the proliferation and initial terminal differentiation processes of the transplanted cells at the transplant site after transplantation to be omitted. Furthermore, it provides a solution to the problems associated with satellite stem cells, which have quantitative limitations, and skeletal muscle progenitor cells, which have low success rates for proliferation and initial terminal differentiation at the transplant site after transplantation. Additionally, it can increase the contractility of skeletal muscle (physiological activity of skeletal muscle) by enhancing the ability to supply calcium for skeletal muscle contraction at the transplant site.

Images